APPLICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION  

作　　者：DPLu NLGuo XJHuang JZhang YMFan QShi BJiang 

机构地区：[1]InstituteofHematology,BeijingMedicalUniversityBeijing100044,InstituteofHematology,BeijingMedicalUniversityBeijing100044,InstituteofHematology,BeijingMedicalUniversityBeijing100044,InstituteofHematology,BeijingMedicalUniversityBeijing100044,InstituteofHema

出　　处：《Chinese Medical Journal》1994年第10期19-20,共2页中华医学杂志（英文版）

摘　　要：The effect of rhG-CSF (Filgrastim by Amgen Co.as Neupogen and Kirin Co.as Gran) was evaluated in 20 patients with leukemia after allogeneic

关 键 词：BMT APPLICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR FILGRASTIM 

分 类 号：R733.7[医药卫生—肿瘤]